TBPH icon

Theravance Biopharma
TBPH

Overview Fund Activity

118 hedge funds and large institutions have $449M invested in Theravance Biopharma in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 24 closing their positions.

Holders
118
Holders Change
+10
Holders Change %
+9.26%
% of All Funds
2.07%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
35
Increased
42
Reduced
21
Closed
24
Calls
$8.44M
Puts
$4.48M
Net Calls
+$3.96M
Net Calls Change
+$3.35M

Top Buyers

1
MAP
1
Madison Avenue Partners
New York
$36.5M
2
BG
2
Baupost Group
Massachusetts
$101M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$25.2M
4
CCM
4
Camber Capital Management
Massachusetts
$18.5M
5
WP
5
Woodline Partners
California
$14.6M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.85M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$19.8M
3
MS
3
Maven Securities
Jersey
$0
4
DCM
4
DAFNA Capital Management
California
$0
5
HCM
5
Highbridge Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MPWT
151
MassMutual Private Wealth & Trust
Connecticut
$0 39 +39 New
3 4 5 6
7